Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashFree Cash FlowNet Cash FlowNet IncomeOther Working Capital Changes
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kairos Pharma (KAPA) Net Income (2024 - 2025)

Historic Net Income for Kairos Pharma (KAPA) over the last 2 years, with Q2 2025 value amounting to -$1.4 million.

  • Kairos Pharma's Net Income fell 50769.23% to -$1.4 million in Q2 2025 from the same period last year, while for Jun 2025 it was -$5.2 million, marking a year-over-year change of. This contributed to the annual value of -$3.0 million for FY2024, which is 7158.31% down from last year.
  • Kairos Pharma's Net Income amounted to -$1.4 million in Q2 2025, which was down 50769.23% from -$1.3 million recorded in Q1 2025.
  • Kairos Pharma's 5-year Net Income high stood at -$234000.0 for Q2 2024, and its period low was -$1.6 million during Q4 2024.